Report
Debbie Wang
EUR 100.00 For Business Accounts Only

Dexcom's recent approval of G6 should goose revenue growth in 2018.

Despite Dexcom’s well-established track record for introducing the most precise sensors for use in its continuous glucose monitors, the firm’s main focus on enhancing accuracy of its CGM performance may not be enough to fend off competition. As tougher competition has entered the picture, we think Dexcom must contend with a negative moat trend. We peg Dexcom's fair value estimate at $55 per share and think shares are fully valued.
At this point, we do not think Dexcom has dug itself a moat. Dexc...
Underlying
DEXCOM INC.

DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring systems for use by people with diabetes and by healthcare providers. The company's products include: DecCom G6?, which allows the company's transmitter to run an algorithm to generate a glucose value and to communicate to a patient's mobile device; DexCom G4? PLATINUM, which is used to adjust therapy and to educate and motivate patients to modify their behavior after viewing the effects that specific foods, exercise, stress and medications have on their glucose levels; and DexCom Share?, which transmits glucose information to the mobile devices of designated recipients.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Debbie Wang

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch